Stifel Nicolaus analyst Selman Akyol maintained a Hold rating on Spire (SR – Research Report) today and set a price target of $69.00. The ...

Stifel Nicolaus analyst Matthew Smith, CFA maintained a Buy rating on Post Holdings (POST – Research Report) today and set a price target of ...

e.l.f. Beauty (NYSE:ELF – Free Report) had its target price decreased by Stifel Nicolaus from $115.00 to $105.00 in a research note published on Monday morning,Benzinga reports. Stifel Nicolaus ...

Russel Metals (TSE:RUS – Get Free Report) had its price target cut by equities researchers at Stifel Nicolaus from C$57.00 to C$55.00 in a note issued to investors on Monday,BayStreet.CA reports.

Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe ...

Good day and welcome to the Stifel Financial fourth quarter financial results conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr ...

(RTTNews) - Stifel Financial Corp. (SF) revealed earnings for its fourth quarter that increased from last year and beat the Street estimates. The company's earnings totaled $234.69 million ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The partnership at ...

On Monday, Stifel analysts maintained a Buy rating on ServiceTitan stock (NASDAQ:TTAN) with a steady price target of $120.00. The company, currently trading at $92.56 with a market capitalization ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...